Rosetta Genomics Ltd. (ROSG: Quote) gapped open higher Thursday morning and has continued to rise in early trade. The stock is now up 4.20 at $15.44.
Rosetta Genomics has been climbing for over a week on above average volume and has set a 7-month high. The stock has been rising since it announced that it obtained Medicare coverage for its miRview mets² assay on May 16th.
Click here to receive FREE breaking news email alerts for Rosetta Genomics Ltd. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org